Together with our published studies in prostate cancer cells [13], the results of the current study indicate that OGR1 and GPR4 are likely to have opposing roles in cancer cells, suggesting that they are coupled to different sets of down-stream signaling molecules. This evidence concerns the gene GPR4 and cancer.